Vanguard Group »

Iovance Biotherapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $186M 23M 8.13
2023-09-30 $101M 22M 4.55
2023-06-30 $144M 20M 7.04
2023-03-31 $83M 14M 6.11
2022-12-31 $92M 15M 6.39
2022-06-30 $148M 13M 11.04
2022-03-31 $206M 12M 16.65
2021-09-30 $294M 12M 24.66
2021-06-30 $318M 12M 26.02
2021-03-31 $382M 12M 31.66
2020-12-31 $551M 12M 46.41
2020-09-30 $388M 12M 32.92
2020-06-30 $336M 12M 27.45
2020-03-31 $333M 11M 29.94
2019-12-31 $300M 11M 27.68
2019-09-30 $192M 11M 18.19
2019-03-31 $55M 5.8M 9.51
2018-12-31 $51M 5.8M 8.88
2018-09-30 $46M 4.0M 11.25
2018-06-30 $48M 3.7M 12.80
2018-03-31 $55M 3.3M 16.90
2017-12-31 $22M 2.8M 8.00
2017-09-30 $20M 2.5M 7.82
2017-06-30 $16M 2.2M 7.35